Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2006 1
2007 1
2008 2
2009 3
2010 6
2011 10
2012 9
2013 8
2014 8
2015 10
2016 7
2017 11
2018 9
2019 13
2020 12
2021 8
2022 13
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.
Nowakowski GS, Hong F, Scott DW, Macon WR, King RL, Habermann TM, Wagner-Johnston N, Casulo C, Wade JL, Nagargoje GG, Reynolds CM, Cohen JB, Khan N, Amengual JE, Richards KL, Little RF, Leonard JP, Friedberg JW, Kostakoglu L, Kahl BS, Witzig TE. Nowakowski GS, et al. Among authors: amengual je. J Clin Oncol. 2021 Apr 20;39(12):1329-1338. doi: 10.1200/JCO.20.01375. Epub 2021 Feb 8. J Clin Oncol. 2021. PMID: 33555941 Free PMC article. Clinical Trial.
Monocytes and macrophages in atherogenesis.
Amengual J, Barrett TJ. Amengual J, et al. Curr Opin Lipidol. 2019 Oct;30(5):401-408. doi: 10.1097/MOL.0000000000000634. Curr Opin Lipidol. 2019. PMID: 31361625 Free PMC article. Review.
Hypomethylating Agents in Lymphoma.
Cogan JC, Liu Y, Amengual JE. Cogan JC, et al. Among authors: amengual je. Curr Treat Options Oncol. 2020 Jun 29;21(8):61. doi: 10.1007/s11864-020-00761-9. Curr Treat Options Oncol. 2020. PMID: 32601883 Review.
Chromatin-Remodeled State in Lymphoma.
Liu Y, Gonzalez Y, Amengual JE. Liu Y, et al. Among authors: amengual je. Curr Hematol Malig Rep. 2019 Oct;14(5):439-450. doi: 10.1007/s11899-019-00541-9. Curr Hematol Malig Rep. 2019. PMID: 31489524 Free PMC article. Review.
Queen's gambit: response-adapted win in CAYA with cHL.
Tolu SS, Amengual JE. Tolu SS, et al. Among authors: amengual je. Blood. 2023 Apr 27;141(17):2037-2038. doi: 10.1182/blood.2022019339. Blood. 2023. PMID: 37103949 No abstract available.
Therapeutic Options for Aggressive T-Cell Lymphomas.
Lue JK, Kress A, Amengual JE. Lue JK, et al. Among authors: amengual je. Curr Hematol Malig Rep. 2017 Aug;12(4):269-281. doi: 10.1007/s11899-017-0389-7. Curr Hematol Malig Rep. 2017. PMID: 28573497 Review.
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
O'Connor OA, Lue JK, Sawas A, Amengual JE, Deng C, Kalac M, Falchi L, Marchi E, Turenne I, Lichtenstein R, Rojas C, Francescone M, Schwartz L, Cheng B, Savage KJ, Villa D, Crump M, Prica A, Kukreti V, Cremers S, Connors JM, Kuruvilla J. O'Connor OA, et al. Among authors: amengual je. Lancet Oncol. 2018 Feb;19(2):257-266. doi: 10.1016/S1470-2045(17)30912-9. Epub 2017 Dec 21. Lancet Oncol. 2018. PMID: 29276022 Free PMC article. Clinical Trial.
121 results